|
UBR7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.844790E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.302500E-03 |
| Normal-vs-Stage2 |
7.201000E-01 |
| Normal-vs-Stage3 |
4.756400E-01 |
| Normal-vs-Stage4 |
8.322800E-01 |
| Stage1-vs-Stage2 |
7.980700E-03 |
| Stage1-vs-Stage3 |
1.445450E-04 |
| Stage1-vs-Stage4 |
1.258020E-02 |
| Stage2-vs-Stage3 |
8.019600E-01 |
| Stage2-vs-Stage4 |
9.172000E-01 |
| Stage3-vs-Stage4 |
7.096600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.107570E-01 |
| Normal-vs-AfricanAmerican |
4.097200E-01 |
| Normal-vs-Asian |
3.880800E-01 |
| Caucasian-vs-AfricanAmerican |
4.980000E-02 |
| Caucasian-vs-Asian |
8.255800E-01 |
| AfricanAmerican-vs-Asian |
3.143600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.768600E-01 |
| Normal-vs-Female |
1.570620E-01 |
| Male-vs-Female |
5.979000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.570600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.648400E-02 |
| Normal-vs-Age(61-80Yrs) |
5.693600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.519600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.427800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.101400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.958800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.702200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.868000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.106600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.643700E-04 |
| Normal-vs-Grade 2 |
1.543220E-03 |
| Normal-vs-Grade 3 |
8.187600E-01 |
| Normal-vs-Grade 4 |
5.503800E-02 |
| Grade 1-vs-Grade 2 |
1.048590E-01 |
| Grade 1-vs-Grade 3 |
6.544400E-03 |
| Grade 1-vs-Grade 4 |
6.30569999999775E-05 |
| Grade 2-vs-Grade 3 |
7.194200E-04 |
| Grade 2-vs-Grade 4 |
2.27760000000021E-05 |
| Grade 3-vs-Grade 4 |
1.771800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.14880000001705E-06 |
| Normal-vs-ccB subtype |
1.290390E-01 |
| ccA subtype-vs-ccB subtype |
2.09809947193662E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.307400E-01 |
| Normal-vs-N1 |
2.285600E-02 |
| N0-vs-N1 |
1.948290E-02 |
|
|
